Form 4: iRhythm Officer Sells Shares Under 10b5-1 Plan
Insider Transaction Report
iRhythm Technologies' Chief Communications & Product Officer, Chad Patterson, sold 280 shares of common stock for $184.83 per share under a pre-arranged 10b5-1 plan.
Summary
- Chad Patterson, the Chief Communications & Product Officer of iRhythm Technologies, Inc. (IRTC), reported a sale of common stock.
- The transaction involved the disposition of 280 shares of common stock.
- The shares were sold at a price of $184.83 per share.
- The sale was executed on December 2, 2025, and was made pursuant to a Rule 10b5-1 trading plan.
- These shares were originally acquired by Mr. Patterson through the Issuer's Employee Stock Purchase Plan.
- Following this transaction, Mr. Patterson beneficially owns 43,387 shares of iRhythm Technologies common stock directly.
Sentiment
Score: 5
Explanation: The filing is a standard Form 4 reporting an insider stock sale under a 10b5-1 plan. It is a factual disclosure and does not inherently convey positive or negative sentiment regarding the company's performance or prospects.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This Form 4 filing reports a routine insider stock transaction under a pre-arranged 10b5-1 plan, which is a common practice for corporate executives to sell shares in a compliant manner. It does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: The sale of 280 shares by a Chief Communications & Product Officer is a very small transaction relative to the company's total outstanding shares and is unlikely to have a material impact on shareholder value or perception.
- Employees: The transaction is a personal financial matter for the executive and does not directly impact the broader employee base.
Key Dates
| Date | Description |
|---|---|
| 12/02/2025 | Date of transaction (sale of common stock) |
| 12/03/2025 | Date the Form 4 was signed by attorney-in-fact |
Keywords
iRhythm Technologies, IRTC, Form 4, Insider Transaction, Stock Sale, 10b5-1 Plan, Chad Patterson, Employee Stock Purchase Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.